PulsePoint Announces Record Growth of Programmatic Health Platform

NEW YORK, March 4, 2020 /PRNewswire/ — PulsePoint, a programmatically-powered technology company using real time data to transform healthcare, announced record annual growth of its programmatic health platform, Life by PulsePoint™. PulsePoint’s overall growth strategy capitalizes on its unique strengths and recent investments in health data and technology. Highlights include 200% revenue growth, with self service representing over 50% of total spend on the platform, working with 80% of the top 25 health agencies and 10 of the top 12 Life Science companies. 

The Life platform is powered by Genome by PulsePoint™, a specialized health data technology which creates a unique and precise view of health audiences across hundreds of millions of health endemic and non-endemic web pages and mobile apps. PulsePoint’s proprietary health and patented contextualization technology provides access to 91% of the US digital population, 98% of health care professionals and over 4,000 health segments.

“2019 was a breakout year for PulsePoint with the market validating our health thesis. PulsePoint has developed a suite of products that are solving the legacy challenges for the long underserved healthcare industry,” said Sloan Gaon, CEO of PulsePoint. “Our growth was driven by continued investments in verticalized and automated marketing technology with a focus on health data and health data segments, which enable us to drive results for our DTC and HCP businesses. We are fully leveraging these competitive advantages to solve big problems and an ever evolving new set of market challenges for payors, providers, life science and medical device companies in 2020.”

About PulsePoint
We are a technology company using real time data to transform healthcare. Through machine learning and programmatic automation, we interpret the hard-to-read signals of the health journey to understand the connection points between relevance and engagement. We do this by unifying real-time Digital Determinants of Health™, offline and clinical data to create a unique and precise view of health audiences, that refines, improves and increases its view over time. Visit www.pulsepoint.com for more about the company’s technology and award winning culture.

Media Contact: Maria Simeone, msimeone@pulsepoint.com

View original content:http://www.prnewswire.com/news-releases/pulsepoint-announces-record-growth-of-programmatic-health-platform-301016465.html

SOURCE PulsePoint

Staff

Recent Posts

RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health…

16 minutes ago

AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- ChemLex, a next-generation AI-for-science company, today announced the establishment…

16 minutes ago

Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science

The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…

15 hours ago

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology…

15 hours ago

Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting

Longer-term analyses reinforce duvelisib’s activity across treatment-experienced PTCL populations, including patients with ≥3 prior lines…

15 hours ago